Multicenter, prospective, comparative cohort study evaluating the efficacy and safety of alfuzosin 10 mg with regard to blood pressure in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia with or without antihypertensive med-Reference-Cited by-同舟云学术

Multicenter, prospective, comparative cohort study evaluating the efficacy and safety of alfuzosin 10 mg with regard to blood pressure in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia with or without antihypertensive med

Published:2015-01 Issue: Volume: Page:277
ISSN:1178-1998
Container-title:Clinical Interventions in Aging
language:en
Short-container-title:CIA

Author:

Park Jong,Zhang Li Tao,Lee Sung Won,Park Kwangsung,Chung Woo Sik,Kim Sae Woong,Hyun Jae Seog,Moon Du Geon,Yang Sang-Kuk,Ryu Ji Kan,Yang Dae Yul,Moon Ki Hak,Min Kweon Sik

Publisher

Informa UK Limited

Subject

Geriatrics and Gerontology,General Medicine

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alfuzosin for the medical treatment of benign prostatic hyperplasia and lower urinary tract symptoms: a systematic review of the literature and narrative synthesis;Therapeutic Advances in Urology;2021-01

2. Efficacy of Alfuzosin in Male Patients with Moderate Lower Urinary Tract Symptoms: Is Metabolic Syndrome a Factor Affecting the Outcome?;UROL J;2020

3. Safety and efficacy of tamsulosin, alfuzosin or silodosin as monotherapy for LUTS in BPH - a double-blind randomized trial;CENT EUR J UROL;2017

4. Nocturnal light pollution and underexposure to daytime sunlight: Complementary mechanisms of circadian disruption and related diseases;Chronobiology International;2015-09-14

5. Personalized therapeutics of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia;Clinical Interventions in Aging;2015-03